HCA Healthcare reported strong fourth-quarter 2025 results, with revenues rising 6.7% year over year to $19.5 billion and net income climbing 30.6% to $1.88 billion. Diluted earnings per share increased to $8.14, supported by higher patient volumes, improved same-facility admissions, and gains from facility sales, while adjusted EBITDA grew 10.8% to $4.11 billion.

For the full year 2025, HCA posted revenues of $75.6 billion and net income of $6.78 billion, reflecting continued operational momentum. Management said investments in network expansion, workforce development, and clinical capabilities strengthened performance and positioned the company well heading into 2026.